GREEN GANOTERMA lucida, the hallucinogen popularly known as “green” gel, has a toxic profile that can be fatal for humans, scientists say.
Green gel is often sold as a recreational drug and can be consumed by the human body, which could make it potentially toxic to humans, according to a study published in the American Journal of Preventive Medicine.
Scientists studied the toxicity of 10,567 doses of green gel and found it was 5,000 times more toxic than other recreational drugs.
The report says that it is extremely difficult to detect the toxic level of green-gel at dosages lower than 0.1 milligrams per milliliter of blood.
The study says the levels found to be safe in the study were between 2,500 and 3,000 milligram per millilitre of blood, which would be more than enough to cause acute toxicity in humans.
The researchers say the toxic effects of green Gel appear to be associated with changes in the structure and function of the central nervous system.
The toxic effects were observed in mice, as well as in people with heart and lung diseases, with symptoms appearing in as little as four days, the study said.
The findings suggest that the toxicities of green Gels are due to changes in neurotransmitters in the brain, which are regulated by the central neurotransmitter glutamate.
Glutamate is involved in the processes that regulate mood and sleep, which is why it is often used to treat insomnia and stress.
The study found that people with mild to moderate Alzheimer’s disease showed an increase in the levels of glutamate and a decrease in the concentrations of GABA, which regulate the body’s sleep and wake cycles, according the study.
Dr. Jaimi Bittner, the lead author of the study, said the results of the research are significant because they could be used to determine whether certain medications could be made to reduce the toxicity.
He said the study found a very high level of toxicity with only two doses, but it could be lowered with larger doses.
He also noted that the researchers used a drug that has not been tested on humans, green gel.
Dr Bittcher said that the study was not designed to determine the risk of death from ingesting green gel, but to investigate whether certain drugs could be prescribed to reduce its toxicities.
Dr Stephen Lohmann, an emergency medicine physician at Memorial Hermann in Omaha, Neb., said he is concerned that green gel is being sold in such a manner as a drug to treat chronic pain.
He said he has seen patients taking up to 50 grams of green gels a day for pain management.
He added that he is not a fan of green drugs.
He called it irresponsible for companies to market these medications to treat serious illnesses like Alzheimer’s and Parkinson’s.
Dr Lohman said the researchers may have made a mistake in how they used the data from the study because they didn’t have a placebo group.
He noted that many of the studies that are being used to make medications for Alzheimer’s patients are designed to test drugs that have been approved for other diseases.
He added that a large number of these drugs are approved for Parkinson’s patients and that he thinks the studies should be stopped.
Dr Andrew Hessel, a senior scientist at the National Institute on Drug Abuse, said in an interview that the data showed that green gans have a very toxic profile.
He stressed that the toxicity level of these compounds is only one aspect of their toxicity.
Dr Hessel said that he does not think that the studies are likely to lead to the FDA requiring that drugs be tested on animals for toxicity levels.
He also said that more research is needed to determine what causes these toxicity levels, and that the FDA will likely need to take action to address these concerns.
Dr Jennifer D. Smith, a professor at the University of Pittsburgh Medical Center and co-author of the new study, did not respond to a request for comment.